This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ocera Therapeutics Inc (OCRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 10.13M 15.53M 15.32M 40.93M
Receivables 62.00K 93.00K 898.00K 1.49M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 3.03M 0.00 0.00
Total Current Assets 48.27M 49.29M 16.59M 43.54M
Property, Plant & Equipment, Gross 121.00K 83.00K 2.45M 2.34M
Accumulated Depreciation & Depletion 60.00K 24.00K 1.51M 1.16M
Property, Plant & Equipment, Net 61.00K 59.00K 942.00K 1.17M
Intangibles 171.00K 335.00K 0.00 0.00
Other Non-Current Assets 3.95M 1.54M 0.00 0.00
Total Non-Current Assets 4.78M 2.53M 942.00K 1.17M
Liabilities & Shareholder Equity
Total Assets 53.05M 51.82M 17.53M 44.71M
Accounts Payable 941.00K 1.28M 1.68M 1.97M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 3.50M 0.00 0.00
Total Current Liabilities 2.91M 6.69M 3.12M 9.33M
Long Term Debt 0.00 0.00 0.00 10.73M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 1.00K 137.00K 163.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 1.00K 137.00K 10.90M
Total Liabilities 2.91M 6.69M 3.25M 20.23M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 50.14M 45.13M 14.27M 24.48M
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 155.08M 126.62M 144.41M 131.80M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -104.91M -81.49M -129.47M -106.63M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -27.00K 3.00K -665.00K -683.00K
Total Capitalization 50.14M 45.13M 14.27M 35.22M
Total Equity 50.14M 45.13M 14.27M 24.48M
Total Liabilities & Stock Equity 53.05M 51.82M 17.53M 44.71M
Total Common Shares Outstanding 19.75M 15.30M 2.30M 2.05M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 17.53M 6.15M 2.12M 1.51M
Diluted Weighted Shares Outstanding 17.53M 6.15M 2.12M 1.51M
Number of Employees 16 14 29 47
Number of Part-Time Employees 0 0 0 0
OCRX News

OCRX Ocera Therapeutics Inc

Analysts Ratings for OCRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET OCRX ANALYST REPORT

Brokerage Partners

OCRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs